Fundraising Fox
/Companies
Sign in

Phigenix

Atlanta, US · Georgia corporation

Find your way into Phigenix

Sign up to see every warm intro you have to Phigenix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Phigenix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.

BiotechHealthtechMedical Devices

Founders & leadership

CD
Carlton D. Donald, Ph.DFounder
WH
Wennifer H. DonaldExecutive

Board

RA
RICHARD A. ROY, M.D.Board director
CN
Cynthia N. DayBoard director
KE
Kenneth E. Robinson, M.D.Board director

Reported raises · per SEC filings

Form D private placements

$4.6M disclosed across 2 rounds · 2007–2014

▶$842.4KraisedAug 2015 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • WENNIFER H. DONALDExecutive Officer, Director
  • CARLTON D. DONALD, PH.DExecutive Officer, Director
  • RICHARD A. ROY, M.D.Director
  • CYNTHIA N. DAYDirector
  • KENNETH E. ROBINSON, M.D.Director
Offering amount
$10.5M
Amount sold
$842.4K
Minimum investment
$35K
First sale
Sep 2014
Incorporated
Corporation, Georgia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedAug 2014 · 78 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wennifer Holmes DonaldDirector
  • Carlton D. Donald, Ph.DExecutive Officer, Director
  • Kenneth E. Robinson, M.D.Director
  • Cynthia DayDirector
Offering amount
$3.7M
Amount sold
$3.7M
Minimum investment
$15K
First sale
Mar 2007
Incorporated
Corporation, Georgia
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.

Companies working in the same space as Phigenix.

Frequently asked questions

What does Phigenix do?
Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
Who founded Phigenix?
Phigenix was founded by Carlton D. Donald, Ph.D.
How much funding has Phigenix raised?
Phigenix has disclosed $4.6M raised across 2 rounds.
Where is Phigenix headquartered?
Phigenix is headquartered in Atlanta, US.